Variable | Men (n = 402) | Women (n = 1004) | ||||
---|---|---|---|---|---|---|
NTN (n = 92) | HTN (n = 301) | HTN + Spiro (n = 9) | NTN (n = 172) | HTN (n = 823) | HTN + Spiro (n = 9) | |
Age (year) | 58 ± 9 | 65 ± 9* | 63 ± 9 | 56 ± 10 | 64 ± 9* | 68 ± 9* |
BMI (kg/m2) | 28 ± 5 | 29 ± 5* | 34 ± 6*# | 31 ± 7+ | 33 ± 7*+ | 33 ± 4 |
HTN medications | 0 | 1.7 ± 1.1* | 2.7 ± 1.3*# | 0 | 1.7 ± 1.1* | 1.8 ± 0.8* |
HTN duration (year) | 0 | 15 ± 12* | 15 ± 11* | 0 | 17 ± 13* | 29 ± 11*#+ |
eGFR (ml/min) | 104 ± 17 | 87 ± 24* | 93 ± 14* | 96 ± 10+ | 87 ± 14* | 79 ± 16* |
LV mass (g/m2) | 75 ± 14 | 90 ± 22* | 90 ± 7* | 68 ± 12+ | 80 ± 18*+ | 73 ± 10+ |
Total urinary protein (mg) | 4 ± 7 | 16 ± 44* | 11 ± 10* | 4 ± 6 | 12 ± 34* | 3 ± 3#+ |
Uncontrolled HTN (%) | 0 | 48* | 44* | 0 | 46* | 0#+ |
CHD (%) | 2 | 17* | 22* | 1 | 9*+ | 11* |
MI (%) | 0 | 10* | 22* | 1 | 4*+ | 11* |
Stroke (%) | 1 | 10* | 22* | 1 | 5*+ | 0 |
Diabetes (%) | 10 | 30* | 11 | 8 | 31* | 33* |